ACETO Subsidiary, Rising Pharmaceuticals, to Launch Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5%
Rising Pharmaceuticals, Inc. | February 03, 2017
ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% an FDA-approved generic version of Valeant International’s Benzamycin® Gel, 3%/5%.